APA (7th ed.) Citation

Klein, E., Tichy, D., Salwender, H., Mai, E. K., Duerig, J., Weisel, K., . . . Goldschmidt, H. (2021). Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial. Cancers, 13(19), . https://doi.org/10.3390/cancers13194856

Chicago Style (17th ed.) Citation

Klein, Eva-Maria, et al. "Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated Within the GMMG-MM5 Trial." Cancers 13, no. 19 (2021). https://doi.org/10.3390/cancers13194856.

MLA (9th ed.) Citation

Klein, Eva-Maria, et al. "Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated Within the GMMG-MM5 Trial." Cancers, vol. 13, no. 19, 2021, https://doi.org/10.3390/cancers13194856.